Keratin immunoreactivity in the benign and neoplastic human prostate
- PMID: 2410099
Keratin immunoreactivity in the benign and neoplastic human prostate
Abstract
Keratin immunoreactivity in the benign and neoplastic human prostate was examined immunohistochemically using two monoclonal antibodies with differing specificities. One of these antibodies stained only the basal cells of the normal and hyperplastic prostatic epithelium, with no reactivity in tumor cells of prostatic adenocarcinoma. The other monoclonal antibody recognized a keratin protein present in all normal and hyperplastic columnar (secretory) epithelial cells, as well as in all cancer cells regardless of degree of tumor differentiation. In addition, the second antibody stained acinar and ductal epithelial cells exhibiting premalignant changes. Our findings indicate that keratin immunoreactivity differs among the epithelial cell populations of the human prostate, probably reflecting expression of different keratin proteins. The distinctive patterns of staining obtained with these two antibodies may assist in distinguishing hyperplastic from neoplastic prostatic epithelium, as well as in the recognition of basal cell hyperplasia, transitional cell metaplasia, and premalignant changes.
Similar articles
-
Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.Prostate. 2001 May 15;47(3):149-63. doi: 10.1002/pros.1058. Prostate. 2001. Corrected and republished in: Prostate. 2001 Aug 1;48(3):210-24. doi: 10.1002/pros.1100. PMID: 11351344 Corrected and republished.
-
Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.Prostate. 2001 Aug 1;48(3):210-24. doi: 10.1002/pros.1100. Prostate. 2001. PMID: 11494337
-
Changes in keratin expression during the development of benign prostatic hyperplasia.Eur Urol. 1997;32(3):332-8. Eur Urol. 1997. PMID: 9358223
-
A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate.Pathologica. 1994 Apr;86(2):128-41. Pathologica. 1994. PMID: 7524011 Review.
-
Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.Prostate. 1996 Feb;28(2):98-106. doi: 10.1002/(SICI)1097-0045(199602)28:2<98::AID-PROS4>3.0.CO;2-J. Prostate. 1996. PMID: 8604398 Review.
Cited by
-
Assays for complexed prostate-specific antigen and other advances in the diagnosis of prostate cancer.Rev Urol. 2003;5 Suppl 6(Suppl 6):S10-6. Rev Urol. 2003. PMID: 16985971 Free PMC article.
-
The importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistance.Cell Signal. 2016 May;28(5):348-356. doi: 10.1016/j.cellsig.2016.01.013. Epub 2016 Jan 29. Cell Signal. 2016. PMID: 26829214 Free PMC article. Review.
-
Phenotypic relationships of prostatic intraepithelial neoplasia to invasive prostatic carcinoma.Am J Pathol. 1991 Jan;138(1):119-28. Am J Pathol. 1991. PMID: 1987760 Free PMC article.
-
Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.Am J Pathol. 1999 Dec;155(6):1985-92. doi: 10.1016/S0002-9440(10)65517-4. Am J Pathol. 1999. PMID: 10595928 Free PMC article.
-
Polo-like kinase 1, on the rise from cell cycle regulation to prostate cancer development.Protein Cell. 2012 Mar;3(3):182-97. doi: 10.1007/s13238-012-2020-y. Epub 2012 Mar 23. Protein Cell. 2012. PMID: 22447658 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical